Global Neurovascular Stent Market Growth 2020-2025
According to this study, over the next five years the Neurovascular Stent market will register a 10.8%% CAGR in terms of revenue, the global market size will reach $ 876.1 million by 2025, from $ 581.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurovascular Stent business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Stent market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Neurovascular Stent, covering the supply chain analysis, impact assessment to the Neurovascular Stent market size growth rate in several scenarios, and the measures to be undertaken by Neurovascular Stent companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Carotid artery stents
Intracranial stents
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Gore Medical
Johnson & Johnson
Medtronic
Terumo Medical
MicroPort Scientific
Acandis
Cordis
Stryker
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neurovascular Stent consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Neurovascular Stent market by identifying its various subsegments.
Focuses on the key global Neurovascular Stent manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurovascular Stent with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurovascular Stent submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurovascular Stent Consumption 2015-2025
2.1.2 Neurovascular Stent Consumption CAGR by Region
2.2 Neurovascular Stent Segment by Type
2.2.1 Carotid artery stents
2.2.2 Intracranial stents
2.3 Neurovascular Stent Consumption by Type
2.3.1 Global Neurovascular Stent Consumption Market Share by Type (2015-2020)
2.3.2 Global Neurovascular Stent Revenue and Market Share by Type (2015-2020)
2.3.3 Global Neurovascular Stent Sale Price by Type (2015-2020)
2.4 Neurovascular Stent Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Neurovascular Stent Consumption by Application
2.5.1 Global Neurovascular Stent Consumption Market Share by Type (2015-2020)
2.5.2 Global Neurovascular Stent Value and Market Share by Type (2015-2020)
2.5.3 Global Neurovascular Stent Sale Price by Type (2015-2020)
3 Global Neurovascular Stent by Company
3.1 Global Neurovascular Stent Sales Market Share by Company
3.1.1 Global Neurovascular Stent Sales by Company (2018-2020)
3.1.2 Global Neurovascular Stent Sales Market Share by Company (2018-2020)
3.2 Global Neurovascular Stent Revenue Market Share by Company
3.2.1 Global Neurovascular Stent Revenue by Company (2018-2020)
3.2.2 Global Neurovascular Stent Revenue Market Share by Company (2018-2020)
3.3 Global Neurovascular Stent Sale Price by Company
3.4 Global Neurovascular Stent Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Neurovascular Stent Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Neurovascular Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Neurovascular Stent by Regions
4.1 Neurovascular Stent by Regions
4.2 Americas Neurovascular Stent Consumption Growth
4.3 APAC Neurovascular Stent Consumption Growth
4.4 Europe Neurovascular Stent Consumption Growth
4.5 Middle East & Africa Neurovascular Stent Consumption Growth
5 Americas
5.1 Americas Neurovascular Stent Consumption by Countries
5.1.1 Americas Neurovascular Stent Consumption by Countries (2015-2020)
5.1.2 Americas Neurovascular Stent Value by Countries (2015-2020)
5.2 Americas Neurovascular Stent Consumption by Type
5.3 Americas Neurovascular Stent Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neurovascular Stent Consumption by Regions
6.1.1 APAC Neurovascular Stent Consumption by Regions (2015-2020)
6.1.2 APAC Neurovascular Stent Value by Regions (2015-2020)
6.2 APAC Neurovascular Stent Consumption by Type
6.3 APAC Neurovascular Stent Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Neurovascular Stent by Countries
7.1.1 Europe Neurovascular Stent Consumption by Countries (2015-2020)
7.1.2 Europe Neurovascular Stent Value by Countries (2015-2020)
7.2 Europe Neurovascular Stent Consumption by Type
7.3 Europe Neurovascular Stent Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Neurovascular Stent by Countries
8.1.1 Middle East & Africa Neurovascular Stent Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Neurovascular Stent Value by Countries (2015-2020)
8.2 Middle East & Africa Neurovascular Stent Consumption by Type
8.3 Middle East & Africa Neurovascular Stent Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neurovascular Stent Distributors
10.3 Neurovascular Stent Customer
11 Global Neurovascular Stent Market Forecast
11.1 Global Neurovascular Stent Consumption Forecast (2021-2025)
11.2 Global Neurovascular Stent Forecast by Regions
11.2.1 Global Neurovascular Stent Forecast by Regions (2021-2025)
11.2.2 Global Neurovascular Stent Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neurovascular Stent Forecast by Type
11.8 Global Neurovascular Stent Forecast by Application
12 Key Players Analysis
12.1 Abbott Laboratories
12.1.1 Company Information
12.1.2 Neurovascular Stent Product Offered
12.1.3 Abbott Laboratories Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Abbott Laboratories Latest Developments
12.2 Gore Medical
12.2.1 Company Information
12.2.2 Neurovascular Stent Product Offered
12.2.3 Gore Medical Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Gore Medical Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Neurovascular Stent Product Offered
12.3.3 Johnson & Johnson Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Medtronic
12.4.1 Company Information
12.4.2 Neurovascular Stent Product Offered
12.4.3 Medtronic Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Medtronic Latest Developments
12.5 Terumo Medical
12.5.1 Company Information
12.5.2 Neurovascular Stent Product Offered
12.5.3 Terumo Medical Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Terumo Medical Latest Developments
12.6 MicroPort Scientific
12.6.1 Company Information
12.6.2 Neurovascular Stent Product Offered
12.6.3 MicroPort Scientific Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 MicroPort Scientific Latest Developments
12.7 Acandis
12.7.1 Company Information
12.7.2 Neurovascular Stent Product Offered
12.7.3 Acandis Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Acandis Latest Developments
12.8 Cordis
12.8.1 Company Information
12.8.2 Neurovascular Stent Product Offered
12.8.3 Cordis Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Cordis Latest Developments
12.9 Stryker
12.9.1 Company Information
12.9.2 Neurovascular Stent Product Offered
12.9.3 Stryker Neurovascular Stent Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Stryker Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Neurovascular Stent Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Carotid artery stents
Table 5. Major Players of Intracranial stents
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Neurovascular Stent Consumption Market Share by Type (2015-2020)
Table 8. Global Neurovascular Stent Revenue by Type (2015-2020) ($ million)
Table 9. Global Neurovascular Stent Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Neurovascular Stent Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Neurovascular Stent Consumption Market Share by Application (2015-2020)
Table 13. Global Neurovascular Stent Value by Application (2015-2020)
Table 14. Global Neurovascular Stent Value Market Share by Application (2015-2020)
Table 15. Global Neurovascular Stent Sale Price by Application (2015-2020)
Table 16. Global Neurovascular Stent Sales by Company (2017-2019) (K Units)
Table 17. Global Neurovascular Stent Sales Market Share by Company (2017-2019)
Table 18. Global Neurovascular Stent Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Neurovascular Stent Revenue Market Share by Company (2017-2019)
Table 20. Global Neurovascular Stent Sale Price by Company (2017-2019)
Table 21. Global Neurovascular Stent Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Neurovascular Stent Products Offered
Table 23. Neurovascular Stent Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Neurovascular Stent Consumption by Regions 2015-2020 (K Units)
Table 25. Global Neurovascular Stent Consumption Market Share by Regions 2015-2020
Table 26. Global Neurovascular Stent Value by Regions 2015-2020 ($ Millions)
Table 27. Global Neurovascular Stent Value Market Share by Regions 2015-2020
Table 28. Americas Neurovascular Stent Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Neurovascular Stent Consumption Market Share by Countries (2015-2020)
Table 30. Americas Neurovascular Stent Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Neurovascular Stent Value Market Share by Countries (2015-2020)
Table 32. Americas Neurovascular Stent Consumption by Type (2015-2020) (K Units)
Table 33. Americas Neurovascular Stent Consumption Market Share by Type (2015-2020)
Table 34. Americas Neurovascular Stent Consumption by Application (2015-2020) (K Units)
Table 35. Americas Neurovascular Stent Consumption Market Share by Application (2015-2020)
Table 36. APAC Neurovascular Stent Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Neurovascular Stent Consumption Market Share by Regions (2015-2020)
Table 38. APAC Neurovascular Stent Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Neurovascular Stent Value Market Share by Regions (2015-2020)
Table 40. APAC Neurovascular Stent Consumption by Type (2015-2020) (K Units)
Table 41. APAC Neurovascular Stent Consumption Market Share by Type (2015-2020)
Table 42. APAC Neurovascular Stent Consumption by Application (2015-2020) (K Units)
Table 43. APAC Neurovascular Stent Consumption Market Share by Application (2015-2020)
Table 44. Europe Neurovascular Stent Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Neurovascular Stent Consumption Market Share by Countries (2015-2020)
Table 46. Europe Neurovascular Stent Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Neurovascular Stent Value Market Share by Countries (2015-2020)
Table 48. Europe Neurovascular Stent Consumption by Type (2015-2020) (K Units)
Table 49. Europe Neurovascular Stent Consumption Market Share by Type (2015-2020)
Table 50. Europe Neurovascular Stent Consumption by Application (2015-2020) (K Units)
Table 51. Europe Neurovascular Stent Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Neurovascular Stent Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Neurovascular Stent Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Neurovascular Stent Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Neurovascular Stent Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Neurovascular Stent Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Neurovascular Stent Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Neurovascular Stent Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Neurovascular Stent Consumption Market Share by Application (2015-2020)
Table 60. Neurovascular Stent Distributors List
Table 61. Neurovascular Stent Customer List
Table 62. Global Neurovascular Stent Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Neurovascular Stent Consumption Market Forecast by Regions
Table 64. Global Neurovascular Stent Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Neurovascular Stent Value Market Share Forecast by Regions
Table 66. Global Neurovascular Stent Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Neurovascular Stent Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Neurovascular Stent Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Neurovascular Stent Value Market Share Forecast by Type (2021-2025)
Table 70. Global Neurovascular Stent Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Neurovascular Stent Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Neurovascular Stent Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Neurovascular Stent Value Market Share Forecast by Application (2021-2025)
Table 74. Abbott Laboratories Product Offered
Table 75. Abbott Laboratories Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Abbott Laboratories Main Business
Table 77. Abbott Laboratories Latest Developments
Table 78. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 79. Gore Medical Product Offered
Table 80. Gore Medical Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Gore Medical Main Business
Table 82. Gore Medical Latest Developments
Table 83. Gore Medical Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Product Offered
Table 85. Johnson & Johnson Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 89. Medtronic Product Offered
Table 90. Medtronic Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Medtronic Main Business
Table 92. Medtronic Latest Developments
Table 93. Medtronic Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 94. Terumo Medical Product Offered
Table 95. Terumo Medical Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Terumo Medical Main Business
Table 97. Terumo Medical Latest Developments
Table 98. Terumo Medical Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 99. MicroPort Scientific Product Offered
Table 100. MicroPort Scientific Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. MicroPort Scientific Main Business
Table 102. MicroPort Scientific Latest Developments
Table 103. MicroPort Scientific Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 104. Acandis Product Offered
Table 105. Acandis Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 106. Acandis Main Business
Table 107. Acandis Latest Developments
Table 108. Acandis Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Cordis Product Offered
Table 110. Cordis Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Cordis Main Business
Table 112. Cordis Latest Developments
Table 113. Cordis Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
Table 114. Stryker Product Offered
Table 115. Stryker Neurovascular Stent Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Stryker Main Business
Table 117. Stryker Latest Developments
Table 118. Stryker Basic Information, Company Total Revenue (in $ million), Neurovascular Stent Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Neurovascular Stent
Figure 2. Neurovascular Stent Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Neurovascular Stent Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Neurovascular Stent Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Carotid artery stents
Figure 7. Product Picture of Intracranial stents
Figure 8. Global Neurovascular Stent Consumption Market Share by Type (2015-2020)
Figure 9. Global Neurovascular Stent Value Market Share by Type (2015-2020)
Figure 10. Neurovascular Stent Consumed in Hospitals
Figure 11. Global Neurovascular Stent Market: Hospitals (2015-2020) (K Units)
Figure 12. Global Neurovascular Stent Market: Hospitals (2015-2020) ($ Millions)
Figure 13. Neurovascular Stent Consumed in Ambulatory Surgical Centers
Figure 14. Global Neurovascular Stent Market: Ambulatory Surgical Centers (2015-2020) (K Units)
Figure 15. Global Neurovascular Stent Market: Ambulatory Surgical Centers (2015-2020) ($ Millions)
Figure 16. Neurovascular Stent Consumed in Others
Figure 17. Global Neurovascular Stent Market: Others (2015-2020) (K Units)
Figure 18. Global Neurovascular Stent Market: Others (2015-2020) ($ Millions)
Figure 19. Global Neurovascular Stent Consumption Market Share by Application (2015-2020)
Figure 20. Global Neurovascular Stent Value Market Share by Application (2015-2020)
Figure 21. Global Neurovascular Stent Sales Market Share by Company in 2017
Figure 22. Global Neurovascular Stent Sales Market Share by Company in 2019
Figure 23. Global Neurovascular Stent Revenue Market Share by Company in 2017
Figure 24. Global Neurovascular Stent Revenue Market Share by Company in 2019
Figure 25. Global Neurovascular Stent Sale Price by Company in 2019
Figure 26. Global Neurovascular Stent Consumption Market Share by Regions 2015-2020
Figure 27. Global Neurovascular Stent Value Market Share by Regions 2015-2020
Figure 28. Americas Neurovascular Stent Consumption 2015-2020 (K Units)
Figure 29. Americas Neurovascular Stent Value 2015-2020 ($ Millions)
Figure 30. APAC Neurovascular Stent Consumption 2015-2020 (K Units)
Figure 31. APAC Neurovascular Stent Value 2015-2020 ($ Millions)
Figure 32. Europe Neurovascular Stent Consumption 2015-2020 (K Units)
Figure 33. Europe Neurovascular Stent Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Neurovascular Stent Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Neurovascular Stent Value 2015-2020 ($ Millions)
Figure 36. Americas Neurovascular Stent Consumption Market Share by Countries in 2019
Figure 37. Americas Neurovascular Stent Value Market Share by Countries in 2019
Figure 38. Americas Neurovascular Stent Consumption Market Share by Type in 2019
Figure 39. Americas Neurovascular Stent Consumption Market Share by Application in 2019
Figure 40. United States Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 41. United States Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Neurovascular Stent Consumption Market Share by Countries in 2019
Figure 47. APAC Neurovascular Stent Value Market Share by Regions in 2019
Figure 48. APAC Neurovascular Stent Consumption Market Share by Type in 2019
Figure 49. APAC Neurovascular Stent Consumption Market Share by Application in 2019
Figure 50. China Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 51. China Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 58. India Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 59. India Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Neurovascular Stent Consumption Market Share by Countries in 2019
Figure 63. Europe Neurovascular Stent Value Market Share by Countries in 2019
Figure 64. Europe Neurovascular Stent Consumption Market Share by Type in 2019
Figure 65. Europe Neurovascular Stent Consumption Market Share by Application in 2019
Figure 66. Germany Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 68. France Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 69. France Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 70. UK Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 71. UK Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Neurovascular Stent Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Neurovascular Stent Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Neurovascular Stent Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Neurovascular Stent Consumption Market Share by Application in 2019
Figure 80. Egypt Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Neurovascular Stent Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Neurovascular Stent Value Growth 2015-2020 ($ Millions)
Figure 90. Global Neurovascular Stent Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Neurovascular Stent Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 93. Americas Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 94. APAC Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 95. APAC Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 96. Europe Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 97. Europe Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 100. United States Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 101. United States Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 102. Canada Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 103. Canada Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 104. Mexico Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 105. Mexico Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 106. Brazil Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 107. Brazil Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 108. China Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 109. China Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 110. Japan Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 111. Japan Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 112. Korea Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 113. Korea Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 116. India Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 117. India Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 118. Australia Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 119. Australia Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 120. Germany Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 121. Germany Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 122. France Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 123. France Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 124. UK Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 125. UK Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 126. Italy Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 127. Italy Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 128. Russia Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 129. Russia Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 130. Spain Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 131. Spain Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 132. Egypt Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 133. Egypt Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 134. South Africa Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 135. South Africa Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 136. Israel Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 137. Israel Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 138. Turkey Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 139. Turkey Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Neurovascular Stent Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Neurovascular Stent Value 2021-2025 ($ Millions)
Figure 142. Abbott Laboratories Neurovascular Stent Market Share (2018-2020)
Figure 143. Gore Medical Neurovascular Stent Market Share (2018-2020)
Figure 144. Johnson & Johnson Neurovascular Stent Market Share (2018-2020)
Figure 145. Medtronic Neurovascular Stent Market Share (2018-2020)
Figure 146. Terumo Medical Neurovascular Stent Market Share (2018-2020)
Figure 147. MicroPort Scientific Neurovascular Stent Market Share (2018-2020)
Figure 148. Acandis Neurovascular Stent Market Share (2018-2020)
Figure 149. Cordis Neurovascular Stent Market Share (2018-2020)
Figure 150. Stryker Neurovascular Stent Market Share (2018-2020)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets